New study published by the HINTT team on the evaluation of a ground-breaking test for pulmonary tuberculosis

HINTT is a research consortium set up in 2017 as part of the GABRIEL network. It has just published the results of a clinical evaluation of RISK6 – a blood test developed for screening and monitoring the treatment of patients suffering from pulmonary tuberculosis.

Next

Previous

Revive

Pause